GTHP
Guided Therapeutics, Inc., a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was incorporated in 1992 and is based in Norcross, Georgia.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2026 Q1 | -0.01 | $0 | -$617,000 |
| 2025 Q4 | -0.01 | $590,000 | -$291,000 |
| 2025 Q3 | -0.01 | $60,000 | -$279,000 |
| 2025 Q2 | -0.01 | $117,000 | -$169,000 |
| 2025 Q1 | -0.01 | $0 | -$331,000 |
| 2024 Q4 | -0.01 | $1,000 | -$332,000 |
| 2024 Q3 | -0.01 | $0 | -$473,000 |
| 2024 Q2 | -0.01 | $0 | -$214,000 |